Post-approval studies (Phase 4)Study completedNCT02078193What this trial is testingEfficacy of Belatacept in Reducing DSAWho this might be right forKidney Transplantation East Carolina University 3
Testing effectiveness (Phase 2)Study completedNCT00001685What this trial is testingImmunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and TyrosinaseWho this might be right forMelanomaNeoplasm Metastasis National Cancer Institute (NCI) 114
Not applicableUnknownNCT03147157What this trial is testingThe Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver TransplantationWho this might be right forLiver TransplantationGraft Versus Host DiseaseGraft Rejection+1 more The First Hospital of Jilin University 120
Not applicableUnknownNCT02304224What this trial is testingThe Relationship of the Use of Eye Masks and Outcomes of Patients With Sepsis in Intensive Care UnitWho this might be right forSepsisSleep DeprivationImmune Suppression Shanghai 10th People's Hospital 100
Not applicableNot Yet RecruitingNCT06774365What this trial is testingCARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart TransplantationWho this might be right forHeart TransplantationRejection Heart TransplantHLA Antigens IRCCS Azienda Ospedaliero-Universitaria di Bologna 683
Very early researchStudy completedNCT00874861What this trial is testingHLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II GliomasWho this might be right forAstrocytomaOligoastrocytomaOligodendroglioma Ian F. Pollack, M.D. 10
Not applicableStudy completedNCT02525042What this trial is testingGenetic Susceptibility to Ankylosing Spondylitis (AS) by Functional Genomics ApproachWho this might be right forAnkylosing Spondylitis Assistance Publique - Hôpitaux de Paris 97
Large-scale testing (Phase 3)Study completedNCT00075816What this trial is testingPeripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)Who this might be right forLeukemiaMyeloproliferative DisordersMyelodysplastic-Myeloproliferative Diseases Medical College of Wisconsin 551
Testing effectiveness (Phase 2)Study completedNCT01341301What this trial is testingDonor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesWho this might be right forHematologic Malignancy Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 25
Testing effectiveness (Phase 2)Ended earlyNCT00090194What this trial is testingImproving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%Who this might be right forKidney Failure, Chronic National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827979What this trial is testingDaratumumab and Belatacept for DesensitizationWho this might be right forHighly Sensitized Prospective Kidney Transplant Recipients National Institute of Allergy and Infectious Diseases (NIAID) 19
Large-scale testing (Phase 3)UnknownNCT02270307What this trial is testingMSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) ProphylaxisWho this might be right forLeukemiaMultiple Myeloma National Research Center for Hematology, Russia 40
Testing effectiveness (Phase 2)Ended earlyNCT02080195What this trial is testingNonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)Who this might be right forLupus ErythematosusGraft-versus-host Disease Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Early research (Phase 1)Study completedNCT00586703What this trial is testingSafety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCTWho this might be right forLymphoma David Rizzieri, MD 21
Early research (Phase 1)Study completedNCT00660166What this trial is testingHuman Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell InfusionsWho this might be right forLymphomaMyelomaLeukemia Tufts Medical Center 13
Post-approval studies (Phase 4)Looking for participantsNCT06676696What this trial is testingStudy to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft FailureWho this might be right forRenal Failure , ChronicGraft FailureGraft Rejection+2 more Hospital Universitari Vall d'Hebron Research Institute 202
Testing effectiveness (Phase 2)Active Not RecruitingNCT04018937What this trial is testingEarly Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell TransplantationWho this might be right forSickle Cell Disease Emory University 43
Early research (Phase 1)Study completedNCT02313857What this trial is testingMost Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)Who this might be right forCMV Infections AlloVir 10
Early research (Phase 1)Looking for participantsNCT07162038What this trial is testingPhase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell TransplantationWho this might be right forHematologic MalignanciesHematologic Neoplasms National Cancer Institute (NCI) 155
Not applicableStudy completedNCT03760952What this trial is testingHuman Leukocyte Antigen Typing and Tumor Antigen Expression ProfilingWho this might be right forRefractory CancerRecurrent CancerAdult Solid Tumor+1 more Immatics US, Inc. 242